Updated recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

The interim recommendations  for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.

For further information, see here.


Tags assigned to this article:

You may have an interest in also reading…

INCB, WHO and UNODC statement on access to internationally controlled medicines during COVID-19 pandemic

Scope (COVID-19 and non-COVID-19 patients affected by the pandemic) The International Narcotics Control Board (INCB), the World Health Organization (WHO)

European Commission: European Semester Autumn Package – Supporting a sustainable and inclusive recovery amid high uncertainty

The European Commission today presented its autumn economic policy package, including the Opinions on euro area Draft Budgetary Plans (DBPs)

UN News: UN urges people to #PledgetoPause before sharing information online

With the COVID-19 pandemic sparking a “communications emergency” caused by false information disseminated on social media, the UN Secretary-General is